SCHEMBL6003249

SCHEMBL6003249

CCCC(Br)(C(=O)O)C(Br)(CCC)C(=O)O

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FFAR3 O14843 2/20 0.35
HDAC3 O15379 1/20 0.35
HDAC1 Q13547 1/20 0.35
HDAC2 Q92769 1/20 0.35
HDAC8 Q9BY41 1/20 0.35
ALDH1A1 P00352 5/20 0.33
FDPS P14324 2/20 0.33
CYP2C19 P33261 2/20 0.33
GAA P10253 1/20 0.33
ALOX12 P18054 1/20 0.33
MEN1 O00255 1/20 0.33
CYP1A2 P05177 1/20 0.33
THRB P10828 1/20 0.33
KMT2A Q03164 1/20 0.33
LMNA P02545 2/20 0.32
HSD17B10 Q99714 1/20 0.32
TSHR P16473 2/20 0.32
KDM4C Q9H3R0 1/20 0.31
HTT P42858 1/20 0.31
CYP2D6 P10635 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6003058 0.84 AKR1B1 (0.39) ALDH1A1MEN1KMT2AHSD17B10TSHR
SCHEMBL6003142 0.82 AKR1B1 (0.42) ALDH1A1MEN1KMT2AHSD17B10TSHR
SCHEMBL6001993 0.80 CES2 (0.45) ALDH1A1MEN1KMT2AHSD17B10TSHR
SCHEMBL31324774 0.78
SCHEMBL10412072 0.78 HDAC1 (0.36) FFAR3HDAC3HDAC1HDAC2HDAC8
SCHEMBL140406 0.76
SCHEMBL1732836 0.74 MEN1 (0.35) FFAR3HDAC3HDAC1HDAC2HDAC8
SCHEMBL1732567 0.74 MEN1 (0.35) FFAR3HDAC3HDAC1HDAC2HDAC8
SCHEMBL1036503 0.74 MEN1 (0.35) FFAR3HDAC3HDAC1HDAC2HDAC8
SCHEMBL2703490 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060217565-A1 Process for producing chromone compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2006-09-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060217565-A1 Process for producing chromone compound ENY2, CDY1; CDY1B, CDYL FFAR3 559/4885HDAC3 591/4885HDAC1 1175/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.